Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Capricor Therapeutics Inc’s stock clocked out at $28.67, up 4.71% from its previous closing price of $27.38. In other words, the price has increased by $4.71 from its previous closing price. On the day, 2.02 million shares were traded. CAPR stock price reached its highest trading level at $29.23 during the session, while it also had its lowest trading level at $27.51.
Ratios:
To gain a deeper understanding of CAPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 1559627520 and an Enterprise Value of 1226725504. For the stock, the TTM Price-to-Sale (P/S) ratio is 140.13 while its Price-to-Book (P/B) ratio in mrq is 15.63. Its current Enterprise Value per Revenue stands at 110.213 whereas that against EBITDA is -14.445.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.23, which has changed by 0.90934443 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $40.37, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 222.68%, while the 200-Day Moving Average is calculated to be 204.72%.
Shares Statistics:
It appears that CAPR traded 2.76M shares on average per day over the past three months and 9674590 shares per day over the past ten days. A total of 45.72M shares are outstanding, with a floating share count of 40.19M. Insiders hold about 12.10% of the company’s shares, while institutions hold 37.87% stake in the company. Shares short for CAPR as of 1763078400 were 14153661 with a Short Ratio of 5.95, compared to 1760486400 on 12248657. Therefore, it implies a Short% of Shares Outstanding of 14153661 and a Short% of Float of 35.22.
Earnings Estimates
. The current rating of Capricor Therapeutics Inc (CAPR) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.47 and low estimates of -$0.58.
Analysts are recommending an EPS of between -$1.9 and -$2.23 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is $0.24, with 8.0 analysts recommending between $3.09 and -$2.57.
